PolicyBrief
S. 2211
119th CongressJul 8th 2025
Special Diabetes Program Reauthorization Act of 2025
IN COMMITTEE

This bill reauthorizes and extends dedicated federal funding for Type 1 Diabetes research and diabetes programs for Native Americans through fiscal year 2027.

Susan Collins
R

Susan Collins

Senator

ME

LEGISLATION

Diabetes Funding Locked In: $160 Million Annually Secured Through 2027 for Type 1 and Native American Programs

The Special Diabetes Program Reauthorization Act of 2025 is essentially a funding lifeline, ensuring that two critical health initiatives don’t run out of gas. This bill extends specific dollar amounts for programs focusing on Type 1 diabetes and those targeting diabetes in Native American communities through the end of 2027.

The Money Breakdown: What’s Being Renewed

This legislation isn't creating new programs; it's confirming the continued operation of existing, established ones. For both the Type 1 Diabetes Programs (under Section 330B(b)(2) of the Public Health Service Act) and the Diabetes Programs for Native Americans (Section 330C(c)(2)), the bill sets aside $160 million for fiscal year 2026 and another $160 million for fiscal year 2027. Think of it as stable, guaranteed funding for the next two full years.

Crucially, the bill also addresses the transition period. For the three months between October 1 and December 31, 2027, an additional $40 million is allocated to each program. This prevents a sudden funding cliff at the end of the fiscal year, giving researchers and service providers a smoother runway. All this money is marked as 'available until expended,' meaning it doesn't vanish if it's not spent by a certain date, allowing for long-term planning.

Why This Matters on the Ground

For the millions of Americans living with Type 1 diabetes, this reauthorization means continued investment in research, prevention, and treatment strategies. This funding supports the scientists working on better treatments and potentially a cure. For a young adult managing their condition while navigating college or a new job, stable funding means the resources and support systems they rely on—from clinical trials to specialized care—are secure for the near future.

Similarly, extending the funding for the Native American Diabetes Programs is vital for addressing a significant health disparity. These funds support localized prevention, education, and clinical care within tribal communities, where diabetes rates are often disproportionately high. For a healthcare worker on a reservation, this funding means they can reliably budget for outreach programs, screening events, and necessary medical equipment, rather than worrying about the lights going out on their budget in 18 months. This predictable, multi-year funding allows these critical programs to focus on patient care and long-term strategy, not constant fundraising.